Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2026-04-08 16:39:43 ET · period of report 2026-04-06 · accession 0001857177-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-08 16:39 | 2026-04-06 | KNSA | Moat Ross | COO | S - Sale+OE | $48.58 | -2,367 | 12.0K | -16% | -$115.0K |
| DT | 2026-04-08 16:39 | 2026-04-07 | KNSA | Moat Ross | COO | M - OptEx | — | +2,477 | 14.5K | +21% | — |
| DT | 2026-04-08 16:39 | 2026-04-07 | KNSA | Moat Ross | COO | F - Tax | $48.94 | -774 | 13.7K | -5% | -$37.9K |
| DT | 2026-04-08 16:39 | 2026-04-07 | KNSA | Moat Ross | COO | M - OptEx | $0.00 | -2,477 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2026-04-06 | S | D | 2,367 | $48.58 | 12,029 | D | — | — | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on November 13, 2024. |
| 2 | Common | Class A Ordinary Share | 2026-04-07 | M | A | 2,477 | — | 14,506 | D | — | — | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 3 | Common | Class A Ordinary Share | 2026-04-07 | F | D | 774 | $48.94 | 13,732 | D | — | — | |
| 4 | Derivative | Restricted Share Unit | 2026-04-07 | M | D | 2,477 | $0.00 | 0 | D | — · — to — | 2,477 Class A Ordinary Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F3) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022. (F3) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022. |